Docoh
Loading...

BCDA BioCardia

BioCardia, Inc., headquartered in San Carlos, California, is developing regenerative biologic therapies to treat cardiovascular and respiratory disease. CardiAMP autologous and Neurokinin-1 Receptor Positive allogenic cell therapies are the Company's biotherapeutic platforms in clinical development. The Company's products include the Helix Biotherapeutic Delivery System and its steerable guide and sheath catheter portfolio. BioCardia also partners with other biotherapeutic companies to provide its Helix system and clinical support for their programs studying therapies for the treatment of heart failure, chronic myocardial ischemia, and acute myocardial infarction.

Company profile

Ticker
BCDA, BCDAW
Exchange
CEO
Peter Altman
Employees
Incorporated
Location
Fiscal year end
Former names
Cardo Medical, Inc., CLICKNSETTLE COM INC, NAM CORP, Tiger X Medical, Inc.
SEC CIK
IRS number
232753988

BCDA stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

13 May 21
29 Jul 21
31 Dec 21
Quarter (USD)
Mar 21 Dec 20 Sep 20 Jun 20
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Revenue
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from BioCardia earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 21.5M 21.5M 21.5M 21.5M 21.5M 21.5M
Cash burn (monthly) (positive/no burn) (positive/no burn) 990.67K 1.16M 627.67K 937.25K
Cash used (since last report) n/a n/a 3.92M 4.58M 2.48M 3.71M
Cash remaining n/a n/a 17.58M 16.92M 19.02M 17.79M
Runway (months of cash) n/a n/a 17.7 14.6 30.3 19.0

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
15 Jun 21 Allen Jim L. Stock Option Common stock Grant Aquire A No No 4.43 12,434 55.08K 12,434
15 Jun 21 Moyes Jay M Stock Option Common stock Grant Aquire A No No 4.43 12,434 55.08K 16,355
15 Jun 21 Stertzer Simon H Stock Option Common stock Grant Aquire A No No 4.43 12,434 55.08K 22,642
15 Jun 21 Krasno Richard M Stock Option Common stock Grant Aquire A No No 4.43 12,434 55.08K 12,434
15 Jun 21 Blank Andrew Scott Stock Option Common stock Grant Aquire A No No 4.43 12,434 55.08K 12,434

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis
?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. junior Avg
New words: Accelerated, Additionally, agent, announced, announcing, aware, begun, beneficially, biotechnology, brought, Cap, confidential, create, difficult, directly, discretion, duration, economy, elevated, evolve, exceed, February, fee, FESC, geography, highly, hold, inconsistent, indirectly, Japanese, larger, lesser, Lincoln, maximum, meet, Meeting, mutate, mutually, negotiate, outbreak, Park, partnership, pay, percentage, population, pro, proxy, rata, recognition, registered, Regular, supply, thereunder, timeline, transseptal, upper, variation
Removed: absent, accurately, acquired, adequate, administered, Aid, alleviate, allogenic, anatomy, annum, assessed, assign, assigned, assignment, assistance, back, Bank, bankruptcy, belonged, Borrower, building, cardiomyopathy, care, carried, cease, Chhabria, commercialize, commercially, complaint, complex, conduction, confidence, converted, correction, customary, customize, decline, deducting, default, delay, depending, detail, disbursed, disbursement, discovery, dissolution, DNA, documentation, doubt, ejection, enable, enacted, endpoint, estimated, evidencing, exercised, expired, external, facility, firm, forced, forecasted, formalized, founded, fourth, fraction, futility, generating, guidance, guide, historic, hypertrophic, impacted, Incentive, indirect, Industry, infarction, institutional, introducer, invention, inventorship, investor, involved, involving, judge, July, lack, Lender, letter, lifted, liquidate, listing, loan, Mark, maturity, member, merger, misappropriated, misappropriation, misstated, monthly, Nasdaq, navigate, neurokinin, NOL, obstructive, occur, occurring, October, order, ordinary, par, patent, payable, Paycheck, payroll, pending, perform, performing, positioned, PPP, preceding, preliminary, prepaid, prepayment, preserved, presiding, proceeding, Program, promissory, Protection, protocol, qualified, qualifying, raw, readout, realized, reassigned, reflected, refund, Relief, remediate, representative, request, reserve, resolve, resource, response, restricted, resumption, reverse, reviewed, reviewing, rightfully, robust, satisfaction, scenario, scrap, Security, senior, September, shape, shrinkage, Silicon, small, split, stated, steerable, stellar, submitted, subsequently, substantial, sum, technical, thousand, trade, transition, unavoidable, uncertainty, underwriting, underwritten, unregistered, unremediated, unsecured, usage, utility, Valley, viable, Vincent, volatility, wholly, worsening, write